863. Deputy Ken O'Flynn asked the Minister for Health whether she accepts that confirmation of no clinical audits since 2020 represents a governance gap in the Treatment Abroad Scheme; and the steps she will take to close it. [49309/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading National Treatment Purchase Fund.
27 questions match, newest first.
1419. Deputy Ken O'Flynn asked the Minister for Health whether any national reporting mechanism exists for adverse incidents, safeguarding concerns, regret outcomes or complaints associated with minors referred abroad under publicly funded healthcare pathways. [39778/26]
1420. Deputy Ken O'Flynn asked the Minister for Health whether any standardised post-treatment follow-up protocol applies to minors returning to Ireland following healthcare treatment, assessment or intervention abroad funded directly or indirectly by the State. [39779/26]
1421. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE maintains any national estimate of the number of minors currently engaged in overseas healthcare pathways supported directly or indirectly through public funding arrangements. [39780/26]
567. Deputy Ken O'Flynn asked the Minister for Health whether any monetary approval thresholds exist within the treatment abroad scheme requiring additional sign-off for high-cost procedures; the officials or grades responsible for such approvals; and if she will provide the thresholds currently applied. [36018/26]
568. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates any formal value-for-money assessment process prior to approving exceptionally high-cost procedures abroad; and if so, the methodology used. [36019/26]
569. Deputy Ken O'Flynn asked the Minister for Health the number of Treatment Abroad Scheme applications approved with an estimated cost exceeding in each year since 2020 (details supplied). [36020/26]
570. Deputy Ken O'Flynn asked the Minister for Health whether any applications under the Treatment Abroad Scheme have been refused wholly or partly on financial, budgetary, or proportionality grounds since 2020; and if she will provide annual figures. [36021/26]
571. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost overseas procedures approved under the Treatment Abroad Scheme; and if so, the governance and reporting arrangements applying to that register. [36022/26]
572. Deputy Ken O'Flynn asked the Minister for Health the dates of all internal audit reviews, Comptroller and Auditor General examinations, or other formal oversight reviews conducted in respect of the Treatment Abroad Scheme since 2020; and if copies of findings or recommendations will be provided. [36023/26]
573. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been conducted regarding financial exposure arising from exceptionally high-cost procedures funded under the Treatment Abroad Scheme; and if so, whether she will provide details. [36024/26]
574. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme has any specific governance pathway for novel, experimental, or highly specialised procedures abroad involving significant State expenditure. [36025/26]
575. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme maintains procedure-specific coding or categorisation for any surgical specialties funded abroad; and if so, to provide the categories recorded. [36026/26]
576. Deputy Ken O'Flynn asked the Minister for Health whether the HSE is capable of identifying retrospectively the categories of gender affirmation procedures funded under the Treatment Abroad Scheme through MDT reports, referral documentation, consultant submissions, or reimbursement records. [36027/26]
577. Deputy Ken O'Flynn asked the Minister for Health whether any legal, GDPR, administrative, or policy barrier prevents the Treatment Abroad Scheme from recording anonymised procedure-category data for overseas gender-related surgeries. [36028/26]
578. Deputy Ken O'Flynn asked the Minister for Health whether the Internal Audit Office of the HSE or the Comptroller and Auditor General has ever examined governance, expenditure tracking, safeguarding, or procedure categorisation relating to overseas gender affirmation surgery referrals under the Treatment Abroad Scheme. [36029/26]
579. Deputy Ken O'Flynn asked the Minister for Health whether her Department has requested the introduction of structured reporting or coding mechanisms relating to gender affirmation procedures funded abroad under the Treatment Abroad Scheme. [36030/26]
580. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the Treatment Abroad Scheme on overseas gender-related surgical referrals for each year from 2020 to date. [36031/26]
581. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme records the age profile of persons approved for overseas gender affirmation surgeries. [36032/26]
2050. Deputy Ken O'Flynn asked the Minister for Health the policy framework governing the multidisciplinary team assessment process which forms the clinical basis for applications under the treatment abroad scheme for gender affirmation surgery; whether national clinical guidelines or standards apply to such MDT determinations; and the body responsible for oversight of these standards. [20078/26]
2051. Deputy Ken O'Flynn asked the Minister for Health the number of applications submitted under the treatment abroad scheme for gender affirmation surgery in each year from 2020 to 2026; the number approved; the number refused; and the principal recorded reasons for refusal where applicable. [20079/26]
2053. Deputy Ken O'Flynn asked the Minister for Health the total expenditure under the treatment abroad scheme on gender affirmation surgery in each year from 2020 to 2025 and to-date in 2026, including travel and accommodation costs funded by the State. [20081/26]
2054. Deputy Ken O'Flynn asked the Minister for Health the number of patients funded under the treatment abroad scheme for gender affirmation surgery in each of the years from 2020 to 2025 and to-date in 2026. [20088/26]
2055. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred under the treatment abroad scheme for gender affirmation surgery in each of the years from 2020 to 2025 and to-date in 2026, including surgery, travel, accommodation and associated medical costs. [20089/26]
2060. Deputy Ken O'Flynn asked the Minister for Health the total expenditure by the Health Service Executive under the treatment abroad scheme in respect of gender affirmation surgeries undertaken outside the State in each year from 2020 to 2025 inclusive; the number of individual procedures funded in each year; and the average cost per procedure in each of those years. [20121/26]